Cargando…
Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592748/ https://www.ncbi.nlm.nih.gov/pubmed/28869221 http://dx.doi.org/10.4103/lungindia.lungindia_305_17 |
| _version_ | 1783262933289009152 |
|---|---|
| author | Singh, Navneet |
| author_facet | Singh, Navneet |
| author_sort | Singh, Navneet |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5592748 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55927482017-09-19 Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears? Singh, Navneet Lung India Editorial Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5592748/ /pubmed/28869221 http://dx.doi.org/10.4103/lungindia.lungindia_305_17 Text en Copyright: © 2017 Indian Chest Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Editorial Singh, Navneet Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears? |
| title | Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears? |
| title_full | Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears? |
| title_fullStr | Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears? |
| title_full_unstemmed | Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears? |
| title_short | Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears? |
| title_sort | beyond epidermal growth factor receptor (egfr) and anaplastic lymphoma kinase (alk) testing in advanced non-small cell lung cancer: is the picture as “ros1” as it appears? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592748/ https://www.ncbi.nlm.nih.gov/pubmed/28869221 http://dx.doi.org/10.4103/lungindia.lungindia_305_17 |
| work_keys_str_mv | AT singhnavneet beyondepidermalgrowthfactorreceptoregfrandanaplasticlymphomakinasealktestinginadvancednonsmallcelllungcanceristhepictureasros1asitappears |